Recherche
-
Serum miR-96-5P and miR-339-5P Are Potential Biomarkers for Multiple System Atrophy and Parkinson's Disease
(Frontiers in Aging Neuroscience. vol. 13, pp. 632891, 2021-07-26)Article de revueLibre accès -
Trabectedin plus durvalumab in patients with advanced pretreated soft tissue sarcoma and ovarian carcinoma (TRAMUNE): an open-label, multicenter phase Ib study
(Clinical Cancer Research, 2021-12-29)Article de revue -
Ontology Integration: Approaches and Challenging Issues
(Information Fusion. vol. 71, pp. 38-63, 2021-07)Article de revue -
Time to define common European criteria for therapeutic added value
(Thérapie, 2021-04-24)Article de revue -
The 2019 Global Initiative for Asthma report: Evidence-based or evidence-biased medicine?
(Thérapie. vol. 76, n° 1, pp. 57–58, 2021-02-26)Article de revue -
Tranexamic Acid for the Prevention of Blood Loss after Cesarean Delivery
(New England Journal of Medicine. vol. 384, n° 17, pp. 1623-1634, 2021-04-29)Article de revue -
Fluoxetine for the Symptomatic Treatment of Multiple System Atrophy: The MSA-FLUO Trial
(Movement Disorders, 2021-04-01)Article de revue -
Aspergillose bronchopulmonaire allergique (ABPA) et mucoviscidose : mécanismes, diagnostic et alternatives thérapeutiques
(Revue des Maladies Respiratoires. vol. 38, n° 5, pp. 466-476, 2021-05)Article de revue -
Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants
(HIV Medicine, 2021-07-01)Article de revue -
Multidrug-resistant tuberculosis imported into low-incidence countries-a GeoSentinel analysis, 2008-2020
(Journal of Travel Medicine, 2021-05-12)Article de revue